These mutations lead to the constitutive activation of various signaling pathways in melanoma cells, especially the MAPK (Ras/Raf/MEK/Erk) and AKT (PI3K/Akt/mTOR) pathways [15,39]. This evidence concerns the gene AKT1 and melanoma.